COMMUNIQUÉS West-GlobeNewswire

Auris Regains Compliance with Nasdaq's Minimum Bid Price Requirement

29/03/2018 - 13:01

Zug, Switzerland, March 29, 2018 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology, today announced it [...]

FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the issue of Convertible Notes and Warrants

29/03/2018 - 12:30

FIT Biotech Oy Company release March 29, 2018 at 01:30 pm EET FIT Biotech Oy's Board of Directors has decided on the issue of Convertible Notes and Warrants On December 22, 2017, the Board of Directors of FIT Biotech Oy [...]

MediciNova Announces Results of Phase 2 Clinical Trial of MN-166 (ibudilast) in Methamphetamine Dependence

29/03/2018 - 12:30

LA JOLLA, Calif., March 29, 2018 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV ) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875 [...]

Ravenquest Completes Final Tranche of Non-brokered Financing

29/03/2018 - 12:00

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAWS VANCOUVER, British Columbia, March [...]

Amarin Sponsors Two Scientific Presentations Scheduled for National Kidney Foundation 2018 Spring Clinical Meetings

29/03/2018 - 11:00

BEDMINSTER, N.J. and DUBLIN, Ireland, March 29, 2018 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN ), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve [...]

Esperite (ESP), The Cell Factory presents pre-clinical results on the new products of the 2nd generation EV's drugs for treatment of inflammatory diseases

29/03/2018 - 09:16

Esperite with its biotech company The Cell Factory has acquired from OPBG the full rights to the IP and the international patent family covering the invention and the therapeutic use of the EV's products. In [...]

Veritas Pharma Closes Private Placement

29/03/2018 - 09:10

VANCOUVER, British Columbia, March 29, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt: 2VP ) ( “ Veritas ” or the “Company”) is pleased to announces the closing of a private placement of [...]

VALNEVA to Present on Lyme and Zika at the 18th World Vaccine Congress in Washington, D.C.

29/03/2018 - 08:31

Valneva to Present on Lyme and Zika at the 18 th World Vaccine Congress in Washington, D.C. Presentations to feature progress on Lyme and Zika vaccine candidates Lyon (France), March 29, 2018 - Valneva SE ("Valneva" or [...]

VALNEVA présentera sur Lyme et Zika au 18ème World Vaccine Congress de Washington, D.C.

29/03/2018 - 08:31

Valneva présentera sur Lyme et Zika au 18 ème World Vaccine Congress de Washington, D.C. Les présentations porteront sur les avancées cliniques des candidats vaccins contre la maladie de Lyme et le virus Zika Lyon ( [...]

Shire plc : Rule 2.9 Announcement

29/03/2018 - 08:01

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 29 March 2018 [...]

Saniona AB: Change in number of shares and votes in Saniona AB (publ)

29/03/2018 - 08:01

PRESS RELEASE March 29, 2018 During March, the registered number of shares and votes in Saniona AB (publ) ("Saniona") has increased due to conversion of convertible notes issued pursuant to the convertible notes funding [...]

Shire Reports Regulatory Milestones for Investigational Hereditary Angioedema (HAE) Treatment Lanadelumab

29/03/2018 - 08:01

Shire Reports Regulatory Milestones for Investigational Hereditary Angioedema (HAE) Treatment Lanadelumab The European Medicines Agency (EMA) validates Shire's Marketing Authorization Application for investigational [...]

Herantis Pharma publishes an introductory video on its drug candidate CDNF for the treatment of Parkinson's disease

29/03/2018 - 08:01

Herantis Pharma publishes an introductory video on its drug candidate CDNF for the treatment of Parkinson's disease Herantis Pharma Plc Press release 29 March 2018 at 9:00 am Herantis Pharma Plc ("Herantis") has [...]

Sanofi: EMA to review sotagliflozin as potential treatment for type 1 diabetes

29/03/2018 - 07:31

Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) EMA to review sotagliflozin as potential treatment for type 1 diabetes Paris - March 29, 2018 - The European Medicines Agency (EMA) has accepted for review Sanofi [...]

Sanofi soumet à l'EMA le dossier de la sotagliflozine dans le traitement potentiel du diabète de type 1

29/03/2018 - 07:31

Communiqué de presse Source : Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi soumet à l'EMA le dossier de la sotagliflozine dans le traitement potentiel du diabète de type 1 Paris - Le 29 mars 2018 - L'Agence européenne des [...]

Previously announced Tender Offers by Sanofi to acquire Ablynx will commence on April 4, 2018

29/03/2018 - 07:01

Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Source: Ablynx (Euronext Brussels and Nasdaq: ABLX) Previously announced Tender Offers by Sanofi to acquire Ablynx will commence on April 4, 2018 Prospectus [...]

Les Offres Publiques d'Acquisition annoncées précédemment par Sanofi en vue d'acquérir Ablynx seront lancées le 4 avril 2018

29/03/2018 - 07:01

Communiqué de presse Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Source: Ablynx (Euronext Brussels and Nasdaq: ABLX) Les Offres Publiques d'Acquisition annoncées précédemment par Sanofi en vue d'acquérir Ablynx seront [...]

PREVIOUSLY ANNOUNCED TENDER OFFERS BY SANOFI TO ACQUIRE ABLYNX WILL COMMENCE ON APRIL 4, 2018

29/03/2018 - 07:01

Prospectus approved by the FSMA on March 27, 2018 and to be published on April 3, 2018 Initial acceptance period will commence on April 4, 2018 and expire on May 4, 2018, subject to extension Paris, France and Ghent, [...]

MDxHealth (R): Denominator PR

29/03/2018 - 07:01

Press release Regulated information 29 March 2018, 7 a.m. CET MDxHealth's New Share Capital Amount and New Number of Shares IRVINE, CA, and HERSTAL, BELGIUM - 29 March 2018 - MDxHealth SA (Euronext Brussels: MDXH) (" [...]